[Characteristics of phospholipids of pharyngeal aspirates in newborn infants depending on the use of glucocorticoids in the prenatal period for the prevention of respiratory disorders].
D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D010614:Pharynx; D010743:Phospholipids / Q000032:analysis*; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011295:Prenatal Care; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*; D013501:Surface-Active Agents / Q000032:analysis*
D005938:Glucocorticoids; D010743:Phospholipids; D013501:Surface-Active Agents; D011239:Prednisolone
Kharakteristika fosfolipidov faringeal'nykh aspiratov u novorozhdennykh deteĭ v zavisimosti ot primeneniia gliukokortikoidov v predrodovyĭ period s tsel'iu profilaktiki dykhatel'nykh rasstroĭstv.